CTLA4 genetic variants influence immune regulation and susceptibility of HPV associated cervical cancer
Maylla Cardoso de Oliveira, Giulia Mariane Fortunato, Pamella Rodrigues da Silva, Bianca Lisley Barboza Pacheco, Mariane Ricciardi da Silva, Karen Brajão de Oliveira · 2025
Read CTLA4 genetic variants influence immune regulation and susceptibility of HPV associated cervical cancer by Maylla Cardoso de Oliveira, Giulia Mariane Fortunato, Pamella Rodrigues da Silva, Bianca Lisley Barboza Pacheco, Mariane Ricciardi da Silva, Karen Brajão de Oliveira (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12799842.txt.
Description
Maylla Cardoso de Oliveira and five co-authors review gene variants in an immune checkpoint gene in a paper from two thousand twenty-five. Cervical cancer is driven by persistent infection with high-risk human papillomavirus, yet only some infected women develop cancer. Host genes likely tip the balance.
The gene in question, CTLA4, helps switch T cells off. Its variants can change how much protein is made, how it is handled, and how tightly it binds its partner. Three named variants have been tied to higher cervical cancer risk in prior studies. The authors see these variants as candidate markers for prognosis and as possible targets for immune therapy. The review makes the case for adding host genetics to cervical cancer care.
Catalog record
| CREATOR | Maylla Cardoso de Oliveira, Giulia Mariane Fortunato, Pamella Rodrigues da Silva, Bianca Lisley Barboza Pacheco, Mariane Ricciardi da Silva, Karen Brajão de Oliveira |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |